{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:06:17Z","timestamp":1775653577267,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03252-3","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:15:04Z","timestamp":1770398104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A randomized clinical trial assessing the efficacy of vitamin B prophylaxis in attenuating paclitaxel-induced neuropathy and the imperative use of gabapentin in diabetic ovarian cancer patients"],"prefix":"10.1007","volume":"43","author":[{"given":"Mahitab","family":"Haggagy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Raslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norhan El","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahenda","family":"Ghaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"3252_CR1","unstructured":"NICE. Ovarian cancer: recognition and initial management, Guidance. 2023. https:\/\/www.nice.org.uk\/guidance\/cg122 Last accessed: (2025, May 23)."},{"key":"3252_CR2","unstructured":"Global Cancer Observatory. 2022. https:\/\/gco.iarc.fr\/en Last accessed: (2025, July 15)."},{"key":"3252_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1157306","volume":"14","author":"M Sousa-Pimenta","year":"2023","unstructured":"Sousa-Pimenta M, Estevinho LM, Szopa A, et al. Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel. Front Pharmacol. 2023;14:1157306. https:\/\/doi.org\/10.3389\/fphar.2023.1157306.","journal-title":"Front Pharmacol"},{"issue":"6","key":"3252_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/PPO.0B013E31815A999B","volume":"13","author":"CL Loprinzi","year":"2007","unstructured":"Loprinzi CL, Maddocks-Christianson K, Wolf SL, et al. The paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism. Cancer J. 2007;13(6):399\u2013403. https:\/\/doi.org\/10.1097\/PPO.0B013E31815A999B.","journal-title":"Cancer J"},{"issue":"11","key":"3252_CR5","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1200\/JCO.2010.33.0308","volume":"29","author":"CL Loprinzi","year":"2011","unstructured":"Loprinzi CL, Reeves BN, Dakhil SR, et al. Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol. 2011;29(11):1472\u20138. https:\/\/doi.org\/10.1200\/JCO.2010.33.0308.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3252_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ANA.24951","volume":"81","author":"NP Staff","year":"2017","unstructured":"Staff NP, Grisold A, Grisold W, Windebank AJ. Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol. 2017;81(6):772\u201381. https:\/\/doi.org\/10.1002\/ANA.24951.","journal-title":"Ann Neurol"},{"key":"3252_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/B978-0-12-802973-2.00015-X","volume":"138","author":"R Hanewinckel","year":"2016","unstructured":"Hanewinckel R, Ikram MA, Van Doorn PA. Peripheral neuropathies. Handb Clin Neurol. 2016;138:263\u201382. https:\/\/doi.org\/10.1016\/B978-0-12-802973-2.00015-X.","journal-title":"Handb Clin Neurol"},{"issue":"12","key":"3252_CR8","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny M, Currie GL, Sena ES, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461\u201370. https:\/\/doi.org\/10.1016\/j.pain.2014.09.020.","journal-title":"Pain"},{"issue":"4","key":"3252_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.6004\/jnccn.2015.0057","volume":"13","author":"P de la Morena Barrio","year":"2015","unstructured":"de la Morena Barrio P, Conesa M\u00c1, Gonz\u00e1lez-Billalabeitia E, et al. Delayed recovery and increased severity of paclitaxel-induced peripheral neuropathy in patients with diabetes. J Natl Compr Canc Netw. 2015;13(4):417\u201323. https:\/\/doi.org\/10.6004\/jnccn.2015.0057.","journal-title":"J Natl Compr Canc Netw"},{"key":"3252_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1023\/A:1008344507482","volume":"9","author":"TJ Postma","year":"1998","unstructured":"Postma TJ, Heimans JJ, Muller MJ, Ossenkoppele GJ, Vermorken JB, Aaronson NK. Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy. Ann Oncol. 1998;9:739\u201344. https:\/\/doi.org\/10.1023\/A:1008344507482.","journal-title":"Ann Oncol"},{"issue":"3","key":"3252_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/S40261-019-00882-6","volume":"40","author":"E Salehifar","year":"2020","unstructured":"Salehifar E, Janbabaei G, Hendouei N, Alipour A, Tabrizi N, Avan R. Comparison of the efficacy and safety of pregabalin and duloxetine in taxane-induced sensory neuropathy: a randomized controlled trial. Clin Drug Investig. 2020;40(3):249\u201357. https:\/\/doi.org\/10.1007\/S40261-019-00882-6.","journal-title":"Clin Drug Investig"},{"key":"3252_CR12","doi-asserted-by":"publisher","unstructured":"Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;3CD007076. https:\/\/doi.org\/10.1002\/14651858.CD007076.pub2.","DOI":"10.1002\/14651858.CD007076.pub2"},{"issue":"28","key":"3252_CR13","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","volume":"38","author":"CL Loprinzi","year":"2020","unstructured":"Loprinzi CL, Lacchetti C, Bleeker J, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol. 2020;38(28):3325\u201348. https:\/\/doi.org\/10.1200\/JCO.20.01399.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3252_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.7812\/TPP\/21.204","volume":"26","author":"M Hanna","year":"2022","unstructured":"Hanna M, Jaqua E, Nguyen V, Clay J. B vitamins: functions and uses in medicine. Perm J. 2022;26(2):89\u201397. https:\/\/doi.org\/10.7812\/TPP\/21.204.","journal-title":"Perm J"},{"issue":"1","key":"3252_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/S00520-016-3404-y","volume":"25","author":"JM Schloss","year":"2017","unstructured":"Schloss JM, Colosimo M, Airey C, Masci P, Linnane AW, Vitetta L. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Support Care Cancer. 2017;25(1):195\u2013204. https:\/\/doi.org\/10.1007\/S00520-016-3404-y.","journal-title":"Support Care Cancer"},{"key":"3252_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/349653","volume":"2013","author":"M Rostock","year":"2013","unstructured":"Rostock M, Jaroslawski K, Guethlin C, Ludtke R, Schr\u00f6der S, Bartsch HH. Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture. Evid Based Complement Alternat Med. 2013;2013:349653. https:\/\/doi.org\/10.1155\/2013\/349653.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"12","key":"3252_CR17","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1592\/PHCO.2005.25.12.1817","volume":"25","author":"T Bookwalter","year":"2005","unstructured":"Bookwalter T, Gitlin M. Gabapentin-induced neurologic toxicities. Pharmacotherapy. 2005;25(12):1817\u20139. https:\/\/doi.org\/10.1592\/PHCO.2005.25.12.1817.","journal-title":"Pharmacotherapy"},{"key":"3252_CR18","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v4.0. 2008. https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v4.pdf Last accessed: (2025, January 3)."},{"issue":"1","key":"3252_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.critrevonc.2015.04.011","volume":"96","author":"F De Iuliis","year":"2015","unstructured":"De Iuliis F, Taglieri L, Salerno G, Lanza R, Scarpa S. Taxane induced neuropathy in patients affected by breast cancer: literature review. Crit Rev Oncol Hematol. 2015;96(1):34\u201345. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.04.011.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"3252_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061451","volume":"20","author":"R Zaj\u0105czkowska","year":"2019","unstructured":"Zaj\u0105czkowska R, Kocot-K\u0119pska M, Leppert W, Wrzosek A, Mika J, Wordliczek J. Mechanisms of chemotherapy-induced peripheral neuropathy. Int J Mol Sci. 2019;20(6):1451. https:\/\/doi.org\/10.3390\/ijms20061451.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3252_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.14710\/dimj.v2il.9549","volume":"2","author":"M Silviana","year":"2021","unstructured":"Silviana M, Tugasworo D, Belladonna M. Efficacy of vitamin B1, B6, and B12 forte therapy in peripheral neuropathy patients. DIMJ. 2021;2(1):14\u20139. https:\/\/doi.org\/10.14710\/dimj.v2il.9549.","journal-title":"DIMJ"},{"issue":"5","key":"3252_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31579\/2693-7247\/080","volume":"5","author":"FT Jeenia","year":"2022","unstructured":"Jeenia FT, Sojib FA, Rahman MS, Ara T, Khan R, Tanin Md JU MJ. Neuroprotective effect of vitamin B6 and vitamin B12 against vincristine- induced peripheral neuropathy: a randomized, double- blind, placebo controlled, multicenter trial. J Pharm Pharm Res. 2022;5(5):1\u20139. https:\/\/doi.org\/10.31579\/2693-7247\/080.","journal-title":"J Pharm Pharm Res"},{"issue":"1","key":"3252_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2024-000462","volume":"3","author":"L Renting","year":"2024","unstructured":"Renting L, Zwart NRK, Ueland PM. Vitamin B6 status and chronic chemotherapy-induced peripheral neuropathy: a prospective cohort study among patients with non-metastatic colorectal cancer receiving oxaliplatin-based chemotherapy. BMJ Oncol. 2024;3(1):e000462. https:\/\/doi.org\/10.1136\/bmjonc-2024-000462.","journal-title":"BMJ Oncol"},{"issue":"8","key":"3252_CR24","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1007\/s00520-016-3175-5","volume":"24","author":"LR Solomon","year":"2016","unstructured":"Solomon LR. Functional vitamin B12 deficiency in advanced malignancy: implications for the management of neuropathy and neuropathic pain. Support Care Cancer. 2016;24(8):3489\u201394. https:\/\/doi.org\/10.1007\/s00520-016-3175-5.","journal-title":"Support Care Cancer"},{"issue":"6","key":"3252_CR25","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1111\/ene.14786","volume":"28","author":"J Stein","year":"2021","unstructured":"Stein J, Geisel J, Obeid R. Association between neuropathy and B-vitamins: a systematic review and meta-analysis. Eur J Neurol. 2021;28(6):2054\u201364. https:\/\/doi.org\/10.1111\/ene.14786.","journal-title":"Eur J Neurol"},{"issue":"6","key":"3252_CR26","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.clnu.2013.04.007","volume":"32","author":"JM Schloss","year":"2013","unstructured":"Schloss JM, Colosimo M, Airey C, Masci PP, Linnane AW, Vitetta L. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review. Clin Nutr. 2013;32(6):888\u201393. https:\/\/doi.org\/10.1016\/j.clnu.2013.04.007.","journal-title":"Clin Nutr"},{"issue":"12","key":"3252_CR27","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1007\/s00520-021-06321-7","volume":"29","author":"J Gu","year":"2021","unstructured":"Gu J, Lu H, Chen C. Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis. Support Care Cancer. 2021;29(12):7461\u20139. https:\/\/doi.org\/10.1007\/s00520-021-06321-7.","journal-title":"Support Care Cancer"},{"issue":"3","key":"3252_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/clpt.2011.115","volume":"90","author":"DR Pachman","year":"2011","unstructured":"Pachman DR, Barton DL, Watson JC, Loprinzi CL. Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther. 2011;90(3):377\u201387. https:\/\/doi.org\/10.1038\/clpt.2011.115.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3252_CR29","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.3390\/curroncol28040273","volume":"28","author":"M Sempere-Bigorra","year":"2021","unstructured":"Sempere-Bigorra M, Juli\u00e1n-Rochina I, Cauli O. Chemotherapy-induced neuropathy and diabetes: a scoping review. Curr Oncol. 2021;28(4):3124\u201338. https:\/\/doi.org\/10.3390\/curroncol28040273.","journal-title":"Curr Oncol"},{"issue":"3","key":"3252_CR30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00520-015-2898-z","volume":"24","author":"T Kus","year":"2016","unstructured":"Kus T, Aktas G, Kalender ME, et al. Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study. Support Care Cancer. 2016;24(3):1175\u20139. https:\/\/doi.org\/10.1007\/s00520-015-2898-z.","journal-title":"Support Care Cancer"},{"issue":"10","key":"3252_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204420","volume":"13","author":"TJ Alharbi","year":"2018","unstructured":"Alharbi TJ, Tourkmani AM, Abdelhay O, et al. The association of metformin use with vitamin B12 deficiency and peripheral neuropathy in Saudi individuals with type 2 diabetes mellitus. PLoS One. 2018;13(10):e0204420. https:\/\/doi.org\/10.1371\/journal.pone.0204420.","journal-title":"PLoS One"},{"key":"3252_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2452853","volume":"2017","author":"MA Ahmed","year":"2017","unstructured":"Ahmed MA, Muntingh GL, Rheeder P. Perspectives on peripheral neuropathy as a consequence of metformin-induced vitamin B12 deficiency in T2DM. Int J Endocrinol. 2017;2017:2452853. https:\/\/doi.org\/10.1155\/2017\/2452853.","journal-title":"Int J Endocrinol"},{"issue":"6","key":"3252_CR33","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1089\/jpm.2005.8.1118","volume":"8","author":"JR Ross","year":"2005","unstructured":"Ross JR, Goller K, Hardy J, et al. Gabapentin is effective in the treatment of cancer-related neuropathic pain: A prospective, open-label study. J Palliat Med. 2005;8(6):1118\u201326. https:\/\/doi.org\/10.1089\/jpm.2005.8.1118.","journal-title":"J Palliat Med"},{"issue":"1","key":"3252_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01610-9","volume":"21","author":"Y Pan","year":"2022","unstructured":"Pan Y, Davis PB, Kaebler DC, Blankfield RP, Xu R. Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy. Cardiovasc Diabetol. 2022;21(1):170. https:\/\/doi.org\/10.1186\/s12933-022-01610-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3252_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/SPCARE-2023-004362","volume":"14","author":"TW Chang","year":"2024","unstructured":"Chang TW, Yang FY, Liu YC, Hung CH. Gabapentinoids for chemotherapy-induced peripheral neuropathy: systematic review and meta-analysis. BMJ Support Palliat Care. 2024;14(3):269\u201378. https:\/\/doi.org\/10.1136\/SPCARE-2023-004362.","journal-title":"BMJ Support Palliat Care"},{"issue":"9","key":"3252_CR36","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/CNCR.23008","volume":"110","author":"RD Rao","year":"2007","unstructured":"Rao RD, Michalak JC, Sloan JA, et al. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer. 2007;110(9):2110\u20138. https:\/\/doi.org\/10.1002\/CNCR.23008.","journal-title":"Cancer"},{"issue":"4","key":"3252_CR37","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5603\/GP.A2018.0034","volume":"89","author":"M Magnowska","year":"2018","unstructured":"Magnowska M, Izycka N, Kapo\u0142a-Czyz J, et al. Effectiveness of Gabapentin phgroupacotherapy in chemotherapy-induced peripheral neuropathy. Ginekol Pol. 2018;89(4):200\u201304. https:\/\/doi.org\/10.5603\/GP.A2018.0034.","journal-title":"Ginekol Pol"},{"issue":"2","key":"3252_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/TBJ.13196","volume":"25","author":"M Aghili","year":"2019","unstructured":"Aghili M, Zare M, Mousavi N, et al. Efficacy of gabapentin for the prevention of paclitaxel induced peripheral neuropathy: a randomized placebo controlled clinical trial. Breast J. 2019;25(2):226\u201331. https:\/\/doi.org\/10.1111\/TBJ.13196.","journal-title":"Breast J"},{"issue":"22","key":"3252_CR39","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1002\/cam4.4328","volume":"10","author":"MR Trendowski","year":"2021","unstructured":"Trendowski MR, Lusk CM, Ruterbusch JJ, et al. Chemotherapy-induced peripheral neuropathy in African American cancer survivors: risk factors and quality of life outcomes. Cancer Med. 2021;10(22):8151\u201361. https:\/\/doi.org\/10.1002\/cam4.4328.","journal-title":"Cancer Med"},{"key":"3252_CR40","doi-asserted-by":"publisher","unstructured":"Lustberg M, Loprinzi C. Diagnosis, management and emerging strategies for chemotherapy-induced neuropathy: A MASCC book. Springer; 2021. https:\/\/doi.org\/10.1007\/978-3-030-78663-2.","DOI":"10.1007\/978-3-030-78663-2"},{"key":"3252_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBCAN.2021.188503","author":"M Zhang","year":"2021","unstructured":"Zhang M, Cheng S, Jin Y, Zhao Y, Wang Y. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2021. https:\/\/doi.org\/10.1016\/J.BBCAN.2021.188503.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"3252_CR42","doi-asserted-by":"crossref","unstructured":"Skipper HE. Kinetics of mammary tumor cell growth and implications for therapy. Cancer. 1971;28:1479\u201399. https:\/\/doi.org\/10.1002\/1097-0142(197112)28:6<1479::aid-cncr2820280622>3.0.co;2-m.","DOI":"10.1002\/1097-0142(197112)28:6<1479::AID-CNCR2820280622>3.0.CO;2-M"},{"key":"3252_CR43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1200\/JCO.1991.9.2.339","volume":"9","author":"RM Meyer","year":"1991","unstructured":"Meyer RM, Hryniuk WM, Goodyear MD. The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin\u2019s lymphoma. J Clin Oncol. 1991;9:339\u201347. https:\/\/doi.org\/10.1200\/JCO.1991.9.2.339.","journal-title":"J Clin Oncol"},{"key":"3252_CR44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.critrevonc.2017.11.005","volume":"120","author":"Y Lalami","year":"2017","unstructured":"Lalami Y, Klastersky J. Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: an overview about well-established and recently emerging clinical data. Crit Rev Oncol Hematol. 2017;120:163\u201379. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.11.005.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"14","key":"3252_CR45","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1056\/NEJM199504063321401","volume":"332","author":"G Bonadonna","year":"1995","unstructured":"Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med. 1995;332(14):901\u201306. https:\/\/doi.org\/10.1056\/NEJM199504063321401.","journal-title":"N Engl J Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03252-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03252-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03252-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:03:24Z","timestamp":1775649804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03252-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["3252"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03252-3","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of NCI (Approval Date: 10th November 2024\/Approval number: MO2411-505-068-193).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"141"}}